JBF Capital’s Centessa Pharmaceuticals CNTA Stock Holding History

JBF Capital’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,887	Closed	-$830K	–	110
2026 Q1	$830K	Buy	+20,887	New	+$534K	0.12%	53

JBF Capital's CNTA Position: Q2 2026 in Review

JBF Capital sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 20,887 shares — an estimated $830K sold.

JBF Capital first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $830K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

JBF Capital reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
JBF Capital sold 20,887 Centessa Pharmaceuticals shares in Q2 2026, an estimated $830K.
JBF Capital first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
JBF Capital's Centessa Pharmaceuticals position peaked at $830K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on JBF Capital's 13F filing for Q2 2026, filed 13 Aug 2026.